See How Digital Health Has Been Transforming Decentralized Clinical Trials

ObvioHealth shed some light on the topic of How Digital Health Has Been Transforming Decentralized Clinical Trials and what the future holds

Orlando, United States - November 17, 2021 /PressCable/ —

People working in the clinical trial industry are relishing the recent adoption of decentralized clinical trials, and ObvioHealth is at the forefront.

A decentralized clinical trial (alternatively known as a DCT) is by no means a new system; it’s been around for at least a decade. Within 10 years, DCTs have picked up a lot of steam, and as a result, adoption has been consistently growing.

Fast forward to 2020: COVID-19 is rampant and almost every industry has come to a standstill, including clinical trials. In order to help keep transmission rates to a minimum, close-contact clinical trials came to a halt, which paved the way for decentralized clinical trials to take the lead and show their value.

Sponsors can create virtual efficiencies throughout the entire trial process, from discovery to research and treatment. In the long term though, it will be the patients who are the greatest benefactors.

Many aspects of traditional clinical trials are inconvenient for most candidates, such as the commute distance to the site of the trial. This factor alone causes patients to drop off from the trial and retention percentages to dip. By making use of DCTs, researchers are giving patients the best thing ever: ease of access.

There are also socioeconomic barriers to consider with traditional clinical trials that don’t exist when it comes to a decentralized clinical trial, the most notable of which are the hidden costs associated with participating, such as travel, childcare, and lost wages.

This is perhaps why the US population’s participation percentage is slim. A 2019 study estimated that 80% of trials didn’t meet participants’ enrolment deadlines. What’s more, an average of 30% of trial participants will drop out before the trial’s end.

ObvioHealth is a Virtual Research Organization (VRO) leading the digitization of health innovation. Launched in 2017, Obvio tackles the inefficiencies within the trial process through leveraging technologies such as decentralized clinical trials. To find out more about the company and other services it offers, visit the website here: https://www.obviohealth.com/

Contact Info:
Name: Tyler Davis
Email: Send Email
Organization: ObvioHealth USA, Inc.
Address: 3452 Lake Lynda Drive Suite 151, Orlando, Florida 32817, United States
Phone: +1-888-880-1664
Website: https://www.obviohealth.com/

Source: PressCable

Release ID: 89053477